The eye-opening experiences of people using LUCENTIS® (ranibizumab injection) for their wet AMD
Click on a picture below to watch a video clip.
Who is LUCENTIS for?
LUCENTIS® (ranibizumab injection) is a prescription medicine for the treatment of patients with Wet Age-Related Macular Degeneration (AMD) and Macular Edema following Retinal Vein Occlusion (RVO).
What important safety information should I know about LUCENTIS?
LUCENTIS is a prescription medication given by injection into the eye, and it has side
effects. Some LUCENTIS patients have had detached retinas and serious infections
inside the eye. LUCENTIS should not be used in patients who have an infection in or
around the eye or are allergic to LUCENTIS or any of its ingredients.
Although not common, LUCENTIS patients have had eye- and non–eye-related blood
clots (heart attacks, strokes, and death).
Some patients have increases in eye pressure within 1 hour of an injection.
Serious side effects include inflammation inside the eye, and rarely, problems related to
the injection procedure, such as developing a cataract. These can make your vision
worse.
The most common side effects to your eye are increased redness in the whites of your
eye, eye pain, small specks in vision, the feeling that something is in your eye. The
most common non–eye-related side effects are nose and throat infections, headache,
and respiratory (lung) infections.
If your eye becomes red, sensitive to light, painful, or has a change in vision, you should
call or visit your eye doctor right away.
By selecting this link, you will be leaving www.LUCENTIS.com and going to a site that is not controlled by or affiliated with Genentech USA, Inc. Genentech is neither affiliated with nor endorses any of the aforementioned organizations. The information provided by Genentech or these organizations is meant for informational purposes only and is not meant to replace your doctor's medical advice.